At
a time when many Democrats are calling for a single-payer health
insurance system, are the drug companies inadvertently driving the
system on a course to that end?
Consider this.
A Health Care Reform Blog––Bob Laszewski's review of the latest developments in federal health policy, health care reform, and marketplace activities in the health care financing business.
Wednesday, January 16, 2019
Wednesday, January 9, 2019
Subscribe to:
Posts (Atom)
Subscribe
Avoid having to check back.
Subscribe to Health Care Policy and Marketplace Review and receive an email each time we post.